NRX Pharmaceuticals, Inc. NRXP Q1 2026 earnings

FAQ

When did NRX Pharmaceuticals, Inc. report Q1 2026 earnings?

NRX Pharmaceuticals, Inc. (NRXP) reported Q1 2026 earnings on May 15, 2026 before market open.

What were NRX Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?

NRX Pharmaceuticals, Inc. reported revenue of $1.1M and eps of $-0.04 for Q1 2026.

Did NRX Pharmaceuticals, Inc. beat estimates in Q1 2026?

Revenue missed the consensus estimate of $19.4M by $18.4M. EPS beat the consensus estimate of $-0.05 by $0.01.

How did NRX Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 53.1% from $2.3M a year earlier and eps grew 88.2% from $-0.34.

Where can I find NRX Pharmaceuticals, Inc.'s Q1 2026 SEC filings?

You can read the 10-Q periodic report (0001437749-26-017397) directly on SEC EDGAR. The filing index links above go to sec.gov.